𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FURTHER CONSIDERATIONS IN THE THERAPY WITH ARA-C

✍ Scribed by W. Kreis

Book ID
114881657
Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
114 KB
Volume
255
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Peripheral neuropathy associated with hi
Peripheral neuropathy associated with high-dose ara-C therapy
✍ Alain Borgeat; Michelle Stalder; Benoit De Muralt πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 283 KB πŸ‘ 1 views

Central nervous system toxicity associated with high-dose cytosine arabinoside (Ara-C) therapy (HD Ara-C) is well known. The authors report the case of a severe isolated peripheral polyneuropathy due to HD Ara-C. Electrophysiologic changes and histologic observations were consistent with axonal dege

Etoposide in combination with intermedia
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy
✍ Dr J. S. Whelan; C. L. Davis; A. Z. S. Rohatiner; M. Leahy; P. K. Maccallum; R. πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 510 KB

Thirty-four patients with refractory or recurrent high grade non-Hodgkin's lymphoma (NHL) or acute leukemia were treated with a combination of etoposide, 100 mg/mZ daily, and ara C, 1 g/m2 twice daily, for 5 days (VPARAC). This therapy was given in the anticipation that remissions thus achieved woul